These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 38643126)

  • 1. Bacterial interactome disturbance in chronic obstructive pulmonary disease clinical stability and exacerbations.
    Xiao W; Chen YL; Du LY; Wu J; Wang Z; Mao B; Wen FQ; Gibson PG; McDonald VM; Yu H; Fu JJ
    Respir Res; 2024 Apr; 25(1):173. PubMed ID: 38643126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammatory Endotype-associated Airway Microbiome in Chronic Obstructive Pulmonary Disease Clinical Stability and Exacerbations: A Multicohort Longitudinal Analysis.
    Wang Z; Locantore N; Haldar K; Ramsheh MY; Beech AS; Ma W; Brown JR; Tal-Singer R; Barer MR; Bafadhel M; Donaldson GC; Wedzicha JA; Singh D; Wilkinson TMA; Miller BE; Brightling CE
    Am J Respir Crit Care Med; 2021 Jun; 203(12):1488-1502. PubMed ID: 33332995
    [No Abstract]   [Full Text] [Related]  

  • 3. Sputum microbiome temporal variability and dysbiosis in chronic obstructive pulmonary disease exacerbations: an analysis of the COPDMAP study.
    Wang Z; Singh R; Miller BE; Tal-Singer R; Van Horn S; Tomsho L; Mackay A; Allinson JP; Webb AJ; Brookes AJ; George LM; Barker B; Kolsum U; Donnelly LE; Belchamber K; Barnes PJ; Singh D; Brightling CE; Donaldson GC; Wedzicha JA; Brown JR;
    Thorax; 2018 Apr; 73(4):331-338. PubMed ID: 29269441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Sputum Microbiome in Chronic Obstructive Pulmonary Disease Exacerbations.
    Huang YJ; Boushey HA
    Ann Am Thorac Soc; 2015 Nov; 12 Suppl 2(Suppl 2):S176-80. PubMed ID: 26595736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Airway host-microbiome interactions in chronic obstructive pulmonary disease.
    Wang Z; Maschera B; Lea S; Kolsum U; Michalovich D; Van Horn S; Traini C; Brown JR; Hessel EM; Singh D
    Respir Res; 2019 Jun; 20(1):113. PubMed ID: 31170986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of exacerbation phenotype with the sputum microbiome in chronic obstructive pulmonary disease patients during the clinically stable state.
    Yang CY; Li SW; Chin CY; Hsu CW; Lee CC; Yeh YM; Wu KA
    J Transl Med; 2021 Mar; 19(1):121. PubMed ID: 33757530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exome and Sputum Microbiota as Predictive Markers of Frequent Exacerbations in Chronic Obstructive Pulmonary Disease.
    Su L; Qiao Y; Luo J; Huang R; Xiao Y
    Biomolecules; 2022 Oct; 12(10):. PubMed ID: 36291689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal profiling of the lung microbiome in the AERIS study demonstrates repeatability of bacterial and eosinophilic COPD exacerbations.
    Mayhew D; Devos N; Lambert C; Brown JR; Clarke SC; Kim VL; Magid-Slav M; Miller BE; Ostridge KK; Patel R; Sathe G; Simola DF; Staples KJ; Sung R; Tal-Singer R; Tuck AC; Van Horn S; Weynants V; Williams NP; Devaster JM; Wilkinson TMA;
    Thorax; 2018 May; 73(5):422-430. PubMed ID: 29386298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics of the sputum microbiome in COPD exacerbations and correlations between clinical indices.
    Su L; Qiao Y; Luo J; Huang R; Li Z; Zhang H; Zhao H; Wang J; Xiao Y
    J Transl Med; 2022 Feb; 20(1):76. PubMed ID: 35123490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exacerbations of chronic obstructive pulmonary disease.
    Wedzicha JA; Donaldson GC
    Respir Care; 2003 Dec; 48(12):1204-13; discussion 1213-5. PubMed ID: 14651761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of sputum microbial metagenome in COPD based on exacerbation frequency and lung function: a case control study.
    Li W; Wang B; Tan M; Song X; Xie S; Wang C
    Respir Res; 2022 Nov; 23(1):321. PubMed ID: 36403054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Airway bacterial concentrations and exacerbations of chronic obstructive pulmonary disease.
    Sethi S; Sethi R; Eschberger K; Lobbins P; Cai X; Grant BJ; Murphy TF
    Am J Respir Crit Care Med; 2007 Aug; 176(4):356-61. PubMed ID: 17478618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Interplay Between Immune Response and Bacterial Infection in COPD: Focus Upon Non-typeable
    Su YC; Jalalvand F; Thegerström J; Riesbeck K
    Front Immunol; 2018; 9():2530. PubMed ID: 30455693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic obstructive pulmonary disease upper airway microbiota alpha diversity is associated with exacerbation phenotype: a case-control observational study.
    Pragman AA; Knutson KA; Gould TJ; Isaacson RE; Reilly CS; Wendt CH
    Respir Res; 2019 Jun; 20(1):114. PubMed ID: 31174538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stability of the frequent COPD exacerbator in the general population: A Danish nationwide register-based study.
    Reilev M; Lykkegaard J; Halling A; Vestbo J; Søndergaard J; Pottegård A
    NPJ Prim Care Respir Med; 2017 Apr; 27(1):25. PubMed ID: 28416794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of ELOM-080 on exacerbations and symptoms in COPD patients with a chronic bronchitis phenotype - a post-hoc analysis of a randomized, double-blind, placebo-controlled clinical trial.
    Beeh KM; Beier J; Candler H; Wittig T
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2877-2884. PubMed ID: 27920515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patients with chronic obstructive pulmonary disease and chronically colonized with Haemophilus influenzae during stable disease phase have increased airway inflammation.
    Tufvesson E; Bjermer L; Ekberg M
    Int J Chron Obstruct Pulmon Dis; 2015; 10():881-9. PubMed ID: 26005341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Airway microbiome dynamics in exacerbations of chronic obstructive pulmonary disease.
    Huang YJ; Sethi S; Murphy T; Nariya S; Boushey HA; Lynch SV
    J Clin Microbiol; 2014 Aug; 52(8):2813-23. PubMed ID: 24850358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The altered sputum microbiome profile in patients with moderate and severe COPD exacerbations, compared to the healthy group in the Indian population.
    Hazra D; Sm F; Chawla K; Sintchenko V; Martinez E; Magazine R; Siddalingaiah N
    F1000Res; 2023; 12():528. PubMed ID: 37928173
    [No Abstract]   [Full Text] [Related]  

  • 20. Frequent exacerbators of chronic obstructive pulmonary disease have distinguishable sputum microbiome signatures during clinical stability.
    Dang X; Kang Y; Wang X; Cao W; Li M; He Y; Pan X; Ye K; Xu D
    Front Microbiol; 2022; 13():1037037. PubMed ID: 36532417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.